A national key R&D program was launched on March 16, 2026, to accelerate the application of nanopore sequencing in the field of pathogen infection detection. This initiative aims to enhance the speed and accuracy of identifying infectious agents, which is crucial for public health response and disease control. The program will foster innovation and collaboration in genomic sequencing technologies for medical diagnostics.
This national program signifies a significant government investment in advanced genomic technologies for public health. Accelerating nanopore sequencing for pathogen detection can lead to faster outbreak responses, improved diagnostics, and a stronger defense against infectious diseases. It positions BGI Genomics and its partners at the forefront of this critical technological development in China.
National key R&D program launched for nanopore sequencing.
Focus on accelerating applications in pathogen infection detection.
Aims to improve speed and accuracy of identifying infectious agents.
The program is a national initiative in China, indicating a strategic focus on strengthening domestic capabilities in advanced diagnostics and public health infrastructure within East Asia.
Focus on accelerating applications in pathogen infection detection.
Aims to improve speed and accuracy of identifying infectious agents.
Sign in to save notes on signals.
Sign In